Home Blog Page 54

Blog

Pharma Marketing Blog

Most popular

Journalists & Physicians Use Superlatives, Some Supplied by FDA – e.g.,...

Pharma Guy - October 29, 2015

Fans & Bananas: Viagra Ads in Japan

Pharma Guy - July 29, 2013

Drug Safety – A Mere Asterisk to the FDA

Pharma Guy - March 6, 2007

Delete This and Delete That, Says Novartis to FDA Regarding Recent...

Pharma Guy - April 16, 2014

An Innovative System for Communicating Drug Risks to Patients

Pharma Guy - September 13, 2007

Update on FDA Regulation of Pharma Metadata & Impact on Search

Pharma Guy - August 9, 2010

Sanofi vs Novartis: Paul Sorvino vs. Paula Deen

Pharma Guy - January 13, 2012

Paula Deen Loses 30 lbs. Urges Twitter Fans to Pig Out...

Pharma Guy - July 2, 2012

Behrman Wasn’t the First Patient Spokesperson Paid Big Bucks By BMS

Pharma Guy - May 20, 2009

Despite FDA Warning Letter, YAZ Web Site Still Connects YAZ with...

Pharma Guy - December 5, 2008

1...535455...240 Page 54 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026